Salim S. Hayek

Emory University — United States

Medicine · Health Sciences

59h-index15.9kcitations371works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(58), Cardiac Valve Diseases and Treatments(27), Cardiac Imaging and Diagnostics(26), Long-Term Effects of COVID-19(26), Chemotherapy-induced cardiotoxicity and mitigation(22)

Publications362 total

Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton’s Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance
Journal of the American College of Cardiology·2025· 1 cited
Abstract 4370557: Cardiovascular Benefits of GLP-1 Receptor Agonists in Non-Obese Patients with Heart-Failure: A Real-World TriNetX Analysis
Circulation·2025
Abstract 4370425: Soluble Urokinase Plasminogen Activator Receptor (suPAR), Lipoprotein(a), and Cardiovascular Outcomes in the Multi-Ethnic Study of Atherosclerosis (MESA)
Circulation·2025
Abstract 4370661: Cardiovascular Benefits of GLP-1 Receptor Agonists in Non-Obese Patients With Type 2 Diabetes, Chronic Kidney Disease, or Coronary Artery Disease: A Real-World TriNetX Analysis
Circulation·2025
Abstract 4370898: Long-Term Impact of GLP-1 Receptor Agonists on Cardiovascular Outcomes in Patients Treated with Hematopoietic Stem Cell Transplantation: A Propensity-Score Matched Analysis
Circulation·2025
374 Soluble uPAR as a Novel Predictor of Mortality Risk in Patients with Skin Cancer
Journal of Investigative Dermatology·2025
Pregnant hospitalized COVID-19 patients: disease, delivery, maternal and fetal outcomes
BMC Pregnancy and Childbirth·2025· 1 citedOpen Access
Targeting CD11b+ Myeloid Cell Recruitment Therapeutically Treats Lupus Nephritis via Reductions in Soluble Urokinase Plasminogen Activator Receptor (suPAR) and C-C Motif Ligand 2 (CCL2) Levels
Journal of the American Society of Nephrology·2025
Soluble Urokinase Plasminogen Activator Receptor and Outcomes in HFpEF: A TOPCAT Ancillary Study
ESC Heart Failure·2025· 2 citedOpen Access
Soluble urokinase plasminogen activator receptor (suPAR) for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes
European Heart Journal Open·2025Open Access
Supplementary Table S1 from A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma
2025Open Access
Supplementary Table S2 from A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma
2025Open Access
Supplementary Table S3 from A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma
2025Open Access
Data from A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma
2025Open Access
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
European Heart Journal·2025· 21 citedOpen Access
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
UNC Libraries·2025Open Access
A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma
Clinical Cancer Research·2025· 2 citedOpen Access
Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long‐Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study
Journal of the American Heart Association·2025· 1 citedOpen Access
Silent Threats Unveiled: The Hidden Pneumothorax in a Chronic Marijuana User
American Journal of Respiratory and Critical Care Medicine·2025
The Reply
The American Journal of Medicine·2025
page 1 of 19Next →

Frequent Co-authors

Samantha K. Brenner(10), Shahzad Shaefi(10), David E. Leaf(10), Shruti Gupta(9), Jochen Reiser(9), Arshed A. Quyyumi(9), Kusum S. Mathews(8), Anand Srivastava(8), Stamatios Lerakis(8), Anita Deswal(7), Lili Chan(7), Adam Green(7), Alexandre M. Shehata(7), Miguel A. Hernán(7), Sarju Ganatra(7), Amanda K. Leonberg‐Yoo(6), Samuel Short(6), Steven G. Coca(6), Ana Barac(6), Adrian F. Hernandez(5)